Portland, OR, May 03, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Antibody Discovery Market by Methods (Phage Display, Hybridoma, Others), by Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody), by End Users (Pharmaceutical and Biotechnology industry, Research laboratory, Academic laboratory): Global Opportunity Analysis and Industry Forecast, 2023-2032”. According to the report, the global antibody discovery industry generated $6.9 billion in 2022, and is anticipated to generate $17.2 billion by 2032, witnessing a CAGR of 9.6% from 2023 to 2032.
Request Sample Report- https://www.alliedmarketresearch.com/request-sample/15282
Prime determinants of growth
The growth of the global antibody discovery market is driven by factors such as increase in investment in R&D activities of antibody discovery, surge in prevalence of infectious and chronic disease, and growth in awareness among individuals regarding early diagnosis detection and personalized medicine. However, high cost of antibody discovery process is hampering the antibody discovery market growth. On the contrary, increase in the number of R&D activities for novel antibody manufacturing and increase in number of key players who provide antibody discovery services are expected to offer remunerative opportunities for expansion of the antibody discovery market during the forecast period.
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2023–2032 |
| Base Year | 2022 |
| Market Size in 2022 | $6.9 billion |
| Market Size in 2032 | $17.2 billion |
| CAGR | 9.6% |
| No. of Pages in Report | 252 |
| Segments covered | Methods, Antibody Type, End Users, and Regions |
| Drivers | Increase in investment in R&D activities of antibody discovery Surge in prevalence of infectious and chronic disease Growth in awareness among individuals regarding early diagnosis detection and personalized medicine |
| Opportunities | Increase in the number of R&D activities for novel antibody manufacturing and increase in number of key players who provide antibody discovery services |
| Restraints | High cost of antibody discovery process |
Covid-19 Scenario
- The COVID-19 outbreak had a positive impact on the growth of the global antibody discovery market.
- The pandemic led to an increased focus on the discovery of new antibodies as well as the exploration of existing antibody treatments. This has resulted in an increased demand for funding and resources for research.
Procure Complete Report (252 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/antibody-discovery-market
The phage display segment to maintain its leadership status throughout the forecast period
Based on methods, the phage display segment held the highest market share in 2022, accounting for nearly half of the global antibody discovery market revenue, and is estimated to maintain its leadership status throughout the forecast period. This segment is also projected to manifest the highest CAGR of 10.1% from 2023 to 2032, owing to advantages of phage display method over other antibody discovery method, increase in R&D activities in healthcare sector, and presence of key players offering phage display method.
The human antibody segment to maintain its leadership status throughout the forecast period
Based on antibody type, the human antibody segment held the highest market share in 2022, accounting for around half of the global antibody discovery market revenue, and is estimated to maintain its leadership status throughout the forecast period. This segment is also projected to manifest the highest CAGR of 10.4% from 2023 to 2032, owing to an increase in demand for human antibody and rise in acceptance and adoption of human antibody drug. Human antibodies are more specific, stable, and cost-effective than murine, chimeric, and humanized antibodies.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/15282
The pharmaceutical and biotechnology industry segment to maintain its lead position during the forecast period
Based on end users, the pharmaceutical and biotechnology industry segment accounted for the largest share in 2022, contributing to nearly three-fifths of the global antibody discovery market revenue. This segment is also expected to portray the largest CAGR of 10.0% from 2023 to 2032 and is projected to maintain its lead position during the forecast period. This is, owing to rise in R&D activities in pharmaceutical & biotechnology industry and surge in expenditure by government to develop advanced pharmaceutical and biotechnology sector.
North America to maintain its dominance by 2032
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global antibody discovery market revenue, and is likely to dominate the market during the forecast period, owing to increase in number of chronic diseases, rise in demand for antibody, surge in R&D activities in pharmaceutical sector, and strong presence of market key players. However, the Asia-Pacific region is expected to witness the fastest CAGR of 11.0% from 2023 to 2032, owing to high prevalence of aging population with increased need of personalized antibody, increase in government fund for development of antibody therapeutics, and surge in healthcare expenditure in this region.
Leading Market Players: -
- Genscript Technology
- Danaher Corporation
- Twist Bioscience HQ
- Sartorius AG
- Charles River Laboratories
- Eurofins Discovery
- Fairjourney Biologics SA
- Biocytogen
- Creative Biolab
- Evotec
The report provides a detailed analysis of these key players of the global antibody discovery market. These players have adopted different strategies such as new product launches, collaborations, joint ventures, agreements, and acquisition to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Trending Reports in Healthcare Industry (Book Now with 20% Discount):
Biomaterials Market by Type (Metallic, Polymeric, Ceramic, and Natural) and Application, (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, and Drug Delivery Systems): Global Opportunity Analysis and Industry Forecast, 2021-2030
Contraceptives Market by Product Type (Drugs, Devices), by Age Group (15-44 Years, Above 44 Years), by End User (Households, Clinics, Hospitals): Global Opportunity Analysis and Industry Forecast, 2020-2030
Healthcare IT Market by Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services), and End User (Healthcare Providers and Healthcare Payers): Global Opportunity Analysis and Industry Forecast, 2021-2030
In Vitro Diagnostics Market By Product And Services (Reagents, Instruments, Software And Services), by Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), by End User (Standalone Laboratories, Hospitals, Academic And Medical Schools, Point Of Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
Laser Hair Removal Market by Type (Alexandrite laser hair removal, Diode laser hair removal, Others), by Gender (Male, Female), by Age group (13 to 29, 30 to 54, 55 to 69), by End User (Hospitals, Clinic, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on Blog: https://www.globalhealthcareindustry.com/
